• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number UNK XIENCE SKYPOINT
Device Problems Difficult to Remove (1528); Defective Device (2588); Patient-Device Incompatibility (2682); Device Damaged by Another Device (2915); Difficult to Advance (2920); Migration (4003)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/01/2022
Event Type  Injury  
Manufacturer Narrative
Date of event estimated.The stent remains in the patient.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.The udi is unknown as the part/lot number were not provided.
 
Event Description
It was reported that the procedure was to treat the distal right coronary artery (rca) with no tortuosity or calcification.The target lesion was an st elevated myocardial infarction (stemi) culprit lesion.The xience skypoint stent was implanted and after deployment, the intervention guide wire was pulled back accidently which required the lesion to be re-wired across the stent.The guidewire caught on the proximal stent edge and the stent moved as the physician was trying to pull the guide wire back but the stent remains fully in the target lesion.The stent was able to be re-crossed and was post-dilated successfully per standard practice.There were no reported adverse patient effects.There was a delay in the procedure but no harm to the patient.No additional information was provided.
 
Event Description
It was reported that the procedure was to treat the distal right coronary artery (rca) with no tortuosity or calcification.The target lesion was an st elevated myocardial infarction (stemi) culprit lesion.The xience skypoint stent was implanted and after deployment, the intervention guidewire was pulled back accidently which required the lesion to be re-wired across the stent.The guidewire caught on the proximal stent edge and the stent moved as the physician was trying to pull the guide wire back but the stent remains fully in the target lesion.The stent was able to be re-crossed and was post-dilated successfully per standard practice.There were no reported adverse patient effects.There was a delay in the procedure but no harm to the patient.Subsequent to the initially filed report, the following information was provided: the stent was under-expanded and undersized.No additional information was provided.
 
Manufacturer Narrative
The device was not returned for evaluation.A review of the lot history record and complaint history of the reported lot could not be conducted because the part and lot number were not provided.The investigation determined the reported difficulties appear to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.B1 - adverse event/product problem: adverse event added.H1 - type of reportable event updated to serious injury.H6 - removed medical device problem code 2920.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key14046103
MDR Text Key288998970
Report Number2024168-2022-03703
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/06/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/07/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNK XIENCE SKYPOINT
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/19/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-